Our study identified early changes in systemic and hepatic inflammation markers that preceded overt evidence of NAFLD, i.e., obesity, insulin resistance, hepatic steatosis and fibrosis in age-matched female and male Ldlr-/- mice. Here, LDLR is linked to metabolic dysfunction-associated steatotic liver disease.